DR. DANIEL ORDEN LUKACZER, ND
Dietitian and Nutritionist at 20 St, Tacoma, WA
License number
Washington NT00000642
Category
Naturopathic
Type
Naturopath
Address
Address
2
6111 20Th St E, Tacoma, WA 98424
5820 98Th Ave NW, Gig Harbor, WA 98335
5820 98Th Ave NW, Gig Harbor, WA 98335
Phone
(253) 926-2222
(253) 265-2772
(253) 853-6766 (Fax)
(253) 265-2772
(253) 853-6766 (Fax)
Professional information
Synergistic Compositions That Treat Or Inhibit Pathological Conditions Associated With Inflammatory Response
US Patent:
8257754, Sep 4, 2012
Filed:
Mar 26, 2012
Appl. No.:
13/430154
Inventors:
Matthew L. Tripp - Gig Harbor WA, US
John G. Babish - Brooktondale NY, US
Jeffrey S. Bland - Fox Island WA, US
Gary K. Darland - Port Orchard WA, US
Robert Lerman - Gig Harbor WA, US
Daniel O. Lukaczer - Gig Harbor WA, US
DeAnn J. Liska - Tacoma WA, US
Terrence M. Howell - Jamaica Plain MA, US
John G. Babish - Brooktondale NY, US
Jeffrey S. Bland - Fox Island WA, US
Gary K. Darland - Port Orchard WA, US
Robert Lerman - Gig Harbor WA, US
Daniel O. Lukaczer - Gig Harbor WA, US
DeAnn J. Liska - Tacoma WA, US
Terrence M. Howell - Jamaica Plain MA, US
Assignee:
Metaproteomics, LLC - San Clemente CA
International Classification:
A01N 65/00
US Classification:
424725
Abstract:
A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
Synergistic Compositions That Treat Or Inhibit Pathological Conditions Associated With Inflammatory Response
US Patent:
7790205, Sep 7, 2010
Filed:
Jan 30, 2006
Appl. No.:
11/344561
Inventors:
Matthew L. Tripp - Gig Harbor WA, US
John G. Babish - Brooktondale NY, US
Jeffrey S. Bland - Fox Island WA, US
Gary K. Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel O. Lukaczer - Gig Harbor WA, US
DeAnn J. Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
John G. Babish - Brooktondale NY, US
Jeffrey S. Bland - Fox Island WA, US
Gary K. Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel O. Lukaczer - Gig Harbor WA, US
DeAnn J. Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
Assignee:
Metaproteomics, LLC - San Clemente CA
International Classification:
A01N 65/00
US Classification:
424725
Abstract:
A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
Synergistic Compositions That Treat Or Inhibit Pathological Conditions Associated With Inflammatory Response
US Patent:
2006012, Jun 15, 2006
Filed:
Jan 30, 2006
Appl. No.:
11/344555
Inventors:
Matthew Tripp - Gig Harbor WA, US
John Babish - Brooktondale NY, US
Jeffrey Bland - Fox Island WA, US
Gary Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel Lukaczer - Gig Harbor WA, US
DeAnn Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
John Babish - Brooktondale NY, US
Jeffrey Bland - Fox Island WA, US
Gary Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel Lukaczer - Gig Harbor WA, US
DeAnn Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
International Classification:
A61K 36/185, A61K 31/12
US Classification:
424778000, 514690000
Abstract:
A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
Compositions That Treat Or Inhibit Pathological Conditions Associated With Inflammatory Response
US Patent:
8486457, Jul 16, 2013
Filed:
Oct 20, 2003
Appl. No.:
10/532388
Inventors:
Matthew L. Tripp - Gig Harbor WA, US
John G. Babish - Brooktondale NY, US
Jeffrey S. Bland - Fox Island WA, US
Gary Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel O. Lukaczer - Gig Harbor WA, US
DeAnn J. Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
John G. Babish - Brooktondale NY, US
Jeffrey S. Bland - Fox Island WA, US
Gary Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel O. Lukaczer - Gig Harbor WA, US
DeAnn J. Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
Assignee:
Metaproteomics, LLC. - San Clemente CA
International Classification:
A01N 65/00
US Classification:
424725
Abstract:
A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
Anti-Inflammatory Pharmaceutical Compositions For Reducing Inflammation And The Treatment Or Prevention Of Gastric Toxicity
US Patent:
7807203, Oct 5, 2010
Filed:
Sep 22, 2009
Appl. No.:
12/564174
Inventors:
John G. Babish - Brooktondale NY, US
Matthew L. Tripp - Gig Harbor WA, US
Jeffrey S. Bland - Fox Island WA, US
Terrence Howell - Jamaica Plain MA, US
Gary K. Darland - Gig Harbor WA, US
Robert H. Lerman - Gig Harbor WA, US
Daniel O. Lukaczer - Gig Harbor WA, US
Matthew L. Tripp - Gig Harbor WA, US
Jeffrey S. Bland - Fox Island WA, US
Terrence Howell - Jamaica Plain MA, US
Gary K. Darland - Gig Harbor WA, US
Robert H. Lerman - Gig Harbor WA, US
Daniel O. Lukaczer - Gig Harbor WA, US
Assignee:
Metaprotemics, LLC - San Clemente CA
International Classification:
A01N 65/00
US Classification:
424725
Abstract:
The invention provides hops () extracts or derivatives thereof for use in treating a patient prophylactically and/or therapeutically for ulcerogenic-type disorders of the stomach and/or intestines. The ulcerogenic disorders can be of the type chemically induced, environmentally-induced, infection-induced, and/or stress-induced. The invention also provides a pharmaceutical composition comprising an active amount of hops extracts or derivatives thereof, in combination with an analgesic compound and/or an anti-inflammatory compound. The invention further provides for use of hops extracts or derivatives thereof, significantly reducing and/or therapeutically treating ulcerogenic-type disorders of the stomach and/or intestines.
Compositions That Treat Or Inhibit Pathological Conditions Associated With Inflammatory Response
US Patent:
8557306, Oct 15, 2013
Filed:
Apr 30, 2012
Appl. No.:
13/459898
Inventors:
Matthew L. Tripp - Gig Harbor WA, US
John G. Babish - Brooktondale NY, US
Jeffrey S. Bland - Fox Island WA, US
Gary K. Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel O. Lukaczer - Gig Harbor WA, US
DeAnn J. Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
John G. Babish - Brooktondale NY, US
Jeffrey S. Bland - Fox Island WA, US
Gary K. Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel O. Lukaczer - Gig Harbor WA, US
DeAnn J. Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
Assignee:
Metaproteomics, LLC - San Clemente CA
International Classification:
A01N 65/00
US Classification:
424725
Abstract:
A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
Synergistic Compositions That Treat Or Inhibit Pathological Conditions Associated With Inflammatory Response
US Patent:
2006012, Jun 15, 2006
Filed:
Jan 30, 2006
Appl. No.:
11/344556
Inventors:
Matthew Tripp - Gig Harbor WA, US
John Babish - Brooktondale NY, US
Jeffrey Bland - Fox Island WA, US
Gary Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel Lukaczer - Gig Harbor WA, US
DeAnn Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
John Babish - Brooktondale NY, US
Jeffrey Bland - Fox Island WA, US
Gary Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel Lukaczer - Gig Harbor WA, US
DeAnn Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
International Classification:
A61K 36/185, A61K 31/12
US Classification:
424778000, 514690000
Abstract:
A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops. Other embodiments relate to combinations of components, including at least one fraction isolated or derived from hops, tryptanthrin and conjugates thereof, rosemary, an extract or compound derived from rosemary, a triterpene species, or a diterpene lactone or derivatives or conjugates thereof.
Modulation Of Inflammation By Hops Fractions And Derivatives
US Patent:
2006012, Jun 15, 2006
Filed:
Jan 30, 2006
Appl. No.:
11/344552
Inventors:
Matthew Tripp - Gig Harbor WA, US
John Babish - Brooktondale NY, US
Jeffrey Bland - Fox Island WA, US
Gary Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel Lukaczer - Gig Harbor WA, US
DeAnn Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
John Babish - Brooktondale NY, US
Jeffrey Bland - Fox Island WA, US
Gary Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel Lukaczer - Gig Harbor WA, US
DeAnn Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
International Classification:
A61K 36/185, A61K 31/12
US Classification:
424778000, 514690000
Abstract:
A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops.
Modulation Of Inflammation By Hops Fractions And Derivatives
US Patent:
7722903, May 25, 2010
Filed:
Jan 30, 2006
Appl. No.:
11/344559
Inventors:
Matthew L. Tripp - Gig Harbor WA, US
John G. Babish - Brooktondale NY, US
Jeffrey S. Bland - Fox Island WA, US
Gary K. Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel O. Lukaczer - Gig Harbor WA, US
DeAnn J. Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
John G. Babish - Brooktondale NY, US
Jeffrey S. Bland - Fox Island WA, US
Gary K. Darland - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
Daniel O. Lukaczer - Gig Harbor WA, US
DeAnn J. Liska - Tacoma WA, US
Terrence Howell - Lansing NY, US
Assignee:
Metaproteomics, LLC - San Clemente CA
International Classification:
A01N 65/00
US Classification:
424725
Abstract:
A natural formulation of compounds that would to modulate inflammation is disclosed. The formulation would also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively in target cells. The compositions containing at least one fraction isolated or derived from hops.
Medical Composition For Managing Hormone Balance
US Patent:
2002019, Dec 19, 2002
Filed:
Jan 23, 2002
Appl. No.:
10/056858
Inventors:
Jeffrey Bland - Fox Island WA, US
DeAnn Liska - Gig Harbor WA, US
Matthew Tripp - Gig Harbor WA, US
Gary Darland - Gig Harbor WA, US
Daniel Lukaczer - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
DeAnn Liska - Gig Harbor WA, US
Matthew Tripp - Gig Harbor WA, US
Gary Darland - Gig Harbor WA, US
Daniel Lukaczer - Gig Harbor WA, US
Robert Lerman - Gig Harbor WA, US
International Classification:
A61K035/78, A61K031/70, A61K031/05
US Classification:
424/745000, 424/757000, 424/756000, 514/023000, 514/027000, 514/053000, 424/755000, 514/733000
Abstract:
A medical composition to nutritionally support hormone balance by promoting estrogen metabolism and increasing its excretion is disclosed. Nutritional support with the medical composition results in improvement in symptoms associated with hormone imbalance. Quality-of-life data and steroid hormone markers also shows improvement over the course of administration of the medical composition.